Business Wire · ALNY · November 9, 2026

Alnylam Announces Five-Year HELIOS-B Data Demonstrating Sustained Benefit of AMVUTTRA® (vutrisiran) in ATTR-CM

Get the app for more

Explore stock news, insights and company research.